Please login to the form below

Not currently logged in
Email:
Password:

Merck KGaA’s Oschmann elected president of IFPMA

He takes over from Lilly’s John Lechleiter
Stefan Oschmann, IFPMA

Global pharma trade body the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has elected Merck KGaA's Stefan Oschmann as its new president.

Oschmann is currently CEO of Merck's pharma business but is due to become deputy CEO of the entire group at the beginning of next year in a shake-up of Merck's leadership.

He succeeds John Lechleiter, chairman, president and CEO at Lilly, who has completed his two-year term after taking over from former AstraZeneca CEO David Brennan.

Oschmann has worked in life sciences for several decades, including roles early in his career at the German Animal Health Federation and the German Chemical Industry Association.

His pharma experience includes an 11-year spell at Merck's US-based namesake Merck & Co, known as MSD outside the US and Canada, before joining Germany-based Merck in 2011.

As president of IFPMA he will head the organisation's work as it engages with international organisations and global health stakeholders on global health policy issues with a focus on innovation and access to quality pharmaceuticals.

Oschmann said he was honoured to take over the role at an important time for global health.

“Current challenges around non-communicable diseases and infectious diseases demonstrate the need for stronger health systems as well as for local innovative solutions in low and middle income countries,” he said.

“As an industry, we will continue to explore how the research-based pharmaceutical industry can sustainably meet the needs and expectations of patients and societies, building on our transformational partnerships to support health goals in these countries.”

5th November 2014

From: Research, Sales, Marketing, Regulatory, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 Women Leaders in UK Healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...

Infographics